Allergan, Inc.
Former American conglomerate / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Allergan, Inc?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
This article is about the original company known as Allergan, Inc., which was acquired by and folded into Actavis. For the new company formed after the acquisition, see Allergan.
Allergan, Inc. was an American global pharmaceutical company focused on eye care, neurosciences, medical dermatology, medical aesthetics, breast enhancement, obesity intervention and urologics. Allergan, Inc. was formed in 1948, incorporated in 1950 and became a public company in 1970.[2] It ceased operation in 2015 when it was acquired by Irish-based Actavis plc (itself a 2013 U.S. tax inversion to Ireland), who then renamed the group as Allergan plc.[3]
Quick Facts Company type, Traded as ...
Company type | Public |
---|---|
NYSE: AGN | |
Industry | Eye care, neurosciences, medical dermatology, medical aesthetics, breast enhancement, obesity intervention and urologics |
Founded | 1948; 76 years ago (1948) |
Defunct | 2015 (2015) |
Fate | Acquired by Actavis plc in 2015, who then renamed the group as Allergan plc |
Successor | Actavis |
Headquarters | Irvine, California, U.S. |
Area served | Over 100 Countries |
Key people | Paul Bisaro (executive chairman) |
Revenue | $6.2 billion (2013)[1] |
Number of employees | 11400 (2013)[1] |
Parent | Allergan plc |
Website | www |
Close